The DOI matches its Crossref record.
Rationale for Revised Penicillin Susceptibility Breakpoints versus Streptococcus pneumoniae:Coping with Antimicrobial Susceptibility in an Era of Resistance
Abstract
In January 2008, the Clinical and Laboratory Standards Institute published revised susceptibility breakpoints for penicillin and Streptococcus pneumoniae, and shortly thereafter, the United States Food and Drug Administration similarly revised its breakpoints via changes in the package insert for penicillin. The revised susceptibility breakpoint is < or =2 microg/mL for nonmeningeal infections treated with parenteral penicillin at a dosage of 12 million units-24 million units per day. The susceptibility breakpoint of < or =0.06 microg/mL remains unchanged for pneumococcal meningitis treated with parenteral penicillin at a dosage of > or =18 million units per day. Herein, we review the scientific basis for the revisions to the breakpoints, which were supported by microbiologic, pharmacokinetic and/or pharmacodynamic, and clinical data. Clinicians, once again, should feel comfortable prescribing penicillin for pneumococcal pneumonia and other pneumococcal infections outside the central nervous system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Bradley, J. S., Byington, C. L., Shah, S. S., Alverson, B., Carter, E. R., Harrison, C., Kaplan, S. L., Mace, S. E., McCracken, G. H., Moore, M. R., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir531 · Cited by 1,919
Gould, F. K., Denning, D. W., Elliott, T. S. J., Foweraker, J., Perry, J. D., Prendergast, B. D., Sandoe, J. A. T., Spry, M. J., & Watkin, R. W. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr450 · Cited by 593
Liñares, J., Ardanuy, C., Pallares, R., & Fenoll, A. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03182.x · Cited by 323
The challenge-and promise-of local clinical practice guidelines
McCulloh, R. J., & Alverson, B. K. (2012) · Pediatrics · doi:10.1542/peds.2012-2085 · Cited by 4
Metadata
- Authors
- Weinstein, M. P., Klugman, K. P., & Jones, R. N.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-06
- Volume
- 48
- Issue
- 11
- Pages
- 1596-1600
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2115070538
- Cited by
- 178
- References
- 0
- FWCI
- 12.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Rationale for Revised Penicillin Susceptibility Breakpoints versus Streptococcus pneumoniae:Coping with Antimicrobial Susceptibility in an Era of Resistance. https://app.cochat.ai/papers/10.1086/598975
- The paper
- Weinstein, M. P., Klugman, K. P., & Jones, R. N. (2009). Rationale for Revised Penicillin Susceptibility Breakpoints versus Streptococcus pneumoniae:Coping with Antimicrobial Susceptibility in an Era of Resistance. Clinical Infectious Diseases. https://doi.org/10.1086/598975
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.